Results 21 to 30 of about 280,561 (284)
Surgical Management of Complications after Dexamethasone Implant [PDF]
Case Reports in Ophthalmological Medicine, 2020 Purpose. To report surgical management of ocular complications occurred after dexamethasone (DEX) implant (Ozurdex®) injection. Methods. Retrospective interventional case series. Results. Different surgical procedures including viscoexpression to manage the migration of the implant into the anterior chamber, “phaco-rolling” technique for the ...
Giancarlo Sborgia +7 more
openaire +5 more sources
Dexamethasone implant – An update
TNOA Journal of Ophthalmic Science and Research, 2020 Uveitic entities may be infectious or noninfectious in etiology. Corticosteroids remain the first-line treatment for noninfectious posterior uveitis.
Richa Pyare, Jyotirmay Biswas
doaj +2 more sources
Brazilian Journal of Pharmaceutical Sciences, 2019 Neuroimmune interactions underlying the development of pain sensitization in models of neuropathic pain have been widely studied. In this study, we evaluated the development of allodynia and its reduction associated with peripheral antineuroinflammatory ...
Leandro Francisco Silva Bastos +12 more
doaj +3 more sources
Splitting of a Dexamethasone Implant (Ozurdex) following the Injection [PDF]
Case Reports in Ophthalmological Medicine, 2013 In this brief report, we share our observations on a splitted Dexamethasone implant (Ozurdex) which we discovered a week after the injection. It is likely that implant splitting neither changes the efficacy of the implant nor creates a mishap for the patient.
Parlak, Melih +3 more
openaire +6 more sources
Acute bacterial endophthalmitis following dexamethasone intravitreal implant: A case report
Saudi Journal of Medicine and Medical Sciences, 2019 A 54-year-old male presented to our ophthalmology clinic with a diagnosis of the right central retinal vein occlusion with macular edema. The patient was treated with dexamethasone intravitreal implant. Three days after the implant insertion, the patient
Waseem Al Zamil, Sanaa A Yassin
doaj +2 more sources
Dexamethasone Implant as Sole Therapy in Sympathetic Ophthalmia [PDF]
Case Reports in Ophthalmology, 2018 We present the case of a 46-year-old woman with sympathetic ophthalmia occurring 27 years after complicated juvenile cataract surgeries. The patient declined systemic immunosuppressive therapy.
Ahmad M. Mansour
doaj +4 more sources
Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective
Clinical Ophthalmology, 2019 Mojca Urbančič,1 Ivana Gardašević Topčić21Eye Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia; 2Department of Ophthalmology, General Hospital in Novo mesto, Ljubljana, SloveniaAbstract: The aim of this article is to provide an ...
Urbančič M, Gardašević Topčić I
doaj +1 more source
Dexamethasone Implant Migration through an Iris Coloboma [PDF]
Case Reports in Ophthalmology, 2020 Ozurdex® 0.7 mg (dexamethasone 0.7 mg implant, Allergan, Dublin, Ireland), an intravitreal biodegradable implant, is indicated for cystoid macular edema due to various causes.
Yoav Glidai +2 more
doaj +3 more sources
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
Clinical Ophthalmology, 2015 Pravin U Dugel,1,2 Francesco Bandello,3 Anat Loewenstein4 1Retinal Consultants of Arizona, Phoenix, AZ, 2Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; 3Department of Ophthalmology ...
Dugel PU, Bandello F, Loewenstein A
doaj +1 more source
Bilateral Intravitreal Dexamethasone Implant for Retinitis Pigmentosa-Related Macular Edema
Case Reports in Ophthalmology, 2013 Purpose: To report the efficacy of intravitreal dexamethasone implant in a patient with retinitis pigmentosa and bilateral cystoid macular edema unresponsive to topical carbonic anhydrase inhibitors.
Ali Osman Saatci +3 more
doaj +2 more sources